SEHK:3899
SEHK:3899Machinery

A Look at CIMC Enric Holdings (SEHK:3899) Valuation Following New Share Buyback Plan

CIMC Enric Holdings (SEHK:3899) has announced plans to activate a previously approved mandate, which allows the company to repurchase up to 1.5% of its issued shares. This move is aimed at boosting shareholder value and supporting market sentiment. See our latest analysis for CIMC Enric Holdings. After a solid share buyback announcement, CIMC Enric Holdings has seen momentum build, with the stock climbing 16.5% over the last 90 days. Its total shareholder return over the past year stands at a...
SEHK:2145
SEHK:2145Personal Products

3 Asian Stocks Estimated To Be Trading Below Their Intrinsic Value By Up To 48.2%

As global markets navigate a complex landscape marked by economic uncertainties and shifting investor sentiment, the Asian stock market presents intriguing opportunities for those seeking value. In this context, identifying stocks trading below their intrinsic value can offer potential for growth, especially as investors look to balance risk with the promise of long-term returns amidst current market conditions.
SEHK:6618
SEHK:6618Consumer Retailing

JD Health International (SEHK:6618) Is Up 15.5% After Technology and Supply Chain Deals With JD.com - Has The Bull Case Changed?

JD Health International reported stronger-than-expected third quarter results, partnered with leading pharmaceutical companies, and announced agreements with JD.com involving technology support, supply chain solutions, and healthcare services, with these deals to be voted on at an upcoming general meeting. JD Health’s advances in digital healthcare and ongoing collaborations have reinforced its leadership in online specialty medicines and expanded the reach of its smart health ecosystem...
SEHK:2598
SEHK:2598Diversified Financial

Exploring Lianlian DigiTech (SEHK:2598) Valuation: Is the Market Overlooking Opportunity?

Lianlian DigiTech (SEHK:2598) has been catching some attention lately, with shares moving in various directions over the past week and month. Investors are weighing recent trading patterns in relation to the company’s overall financial trajectory. See our latest analysis for Lianlian DigiTech. Lianlian DigiTech’s share price has swung lower over the past quarter, with a 90-day share price return of -17.96% and a one-year total shareholder return of -13.4%. While momentum has faded recently,...
SEHK:1548
SEHK:1548Life Sciences

Why Genscript Biotech (SEHK:1548) Is Up 8.0% After Legend Biotech’s CARVYKTI Drives Smaller Q3 Loss

Earlier this week, Genscript Biotech Corporation announced that its associate, Legend Biotech Corporation, reported a significant reduction in net losses for the third quarter of 2025, alongside strong sales growth for its CARVYKTI product. This disclosure, released around Genscript’s Analyst/Investor Day, places enhanced focus on the financial ties between the two companies and the implications for Genscript’s broader business outlook. We’ll now explore how Legend Biotech’s improved...